Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CHO-H01
/
Cho Pharma
Welcome,
Profile
Billing
Logout
0 Diseases
1 Trial
1 Trial
2 News
||
||||||||
CHO-H01
/
Cho Pharma
New P1/2 trial:
A Study to Assess Safety and Efficacy of CHO-H01 in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma
(clinicaltrials.gov) - Jul 20, 2023
P1/2
, N=11, Recruiting,
Sponsor: Cho Pharma Inc.
|
|||||||||
CHO-H01
/
Cho Pharma
Trial initiation date:
A Phase I Study of Intravenous CHO-H01 in Patients With Refractory or Relapsed Follicular Lymphoma
(clinicaltrials.gov) - Jan 24, 2018
P1
, N=24, Not yet recruiting,
Sponsor: Cho Pharma Inc.
Initiation date: Oct 2017 --> Mar 2018
|
|||||||||
CHO-H01
/
Cho Pharma
New P1 trial:
A Phase I Study of Intravenous CHO-H01 in Patients With Refractory or Relapsed Follicular Lymphoma
(clinicaltrials.gov) - Jul 18, 2017
P1
, N=24, Not yet recruiting,
Sponsor: Cho Pharma Inc.